Study of Rituximab in Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease

NCT00472225 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Steroid-Refractory Chronic GVHD

Interventions

DRUG: Rituximab

Sponsor

The Korean Society of Hematopoietic Stem Cell Transplantation

Collaborators

[object Object]